ED
Hirotsu Bioscience develops pancreatic cancer screening test
November 17, 2022, Tokyo, Japan - Akira Suzuki, COO of Hirotsu Bioscience announces the company develops the pancreatic cancer screening test "N-Nose plus Pancreas" using user's urine in Tokyo on Thursday, November 17, 2022. Hirotsu Bioscience developed the new cancer specific test using genetically modifying C. elegans nematodes which react to smell of urine of patients of pancreatic cancer. (Photo by Yoshio Tsunoda/AFLO)
Details
ID
204032839
Collection
License type
Editorial
Photographer
Creation date
17-11-2022
Contact Aflo for all commercial uses.
More
Top Categories